December 2020

Payers play a critical role in promoting high-value patient care, and patient-reported measures (PRMs) and performance measures (PR-PMs) are key to bringing patient voices into value-based care and payment. Discern Health and the National Pharmaceutical Council (NPC) published a call to action for payers in a viewpoint article in the Journal of Managed Care Pharmacy. “Improving Patient-Reported Measures in Oncology: A Payer Call to Action,” which was co-authored by Drs. Mark McClellan and Ethan Basch, outlines the current state of PRMs and PR-PMs in oncology, describes barriers to implementation, and identifies actionable recommendations for public and private payers to accelerate the appropriate use of these measures in oncology value-based payment programs.

This research was also featured in an October 21 presentation at the Academy of Managed Care Pharmacy Nexus 2020 Virtual meeting. Discern Vice President Theresa Schmidt moderated a panel exploring the role of PRMs in value-based contracting, challenges to pharmacy implementation, and how health plans can help drive solutions. Learn more about the presentation here.

Read the JMCP article here. Read NPC’s summary of the article here.

For more information, please contact Theresa Schmidt at tschmidt@discerhealth.com.